| Sources | Names Used |
|---|---|
| CTRPv2 | PRL-3 inhibitor I |
| PharmacoGx | PRL-3 Inhibitor I |
| Database | Identifier |
|---|---|
| Smiles: | Brc1ccc(OCc2ccccc2Br)c(/C=C3/SC(=S)NC3=O)c1 |
| Pubchem: | 11983303 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TYW3 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | SIX3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | CCDC7 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | RRS1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | FUT1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | SLC2A4RG | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | ACOT2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | DDX50 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | ZNF644 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | TINAGL1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
